Unknown

Dataset Information

0

Current Concepts in the Treatment of Multiple System Atrophy.


ABSTRACT: MSA is a progressive neurodegenerative disorder characterized by autonomic failure and a variable combination of poor levodopa-responsive parkinsonism and cerebellar ataxia (CA). Current therapeutic management is based on symptomatic treatment. Almost one third of MSA patients may benefit from l-dopa for the symptomatic treatment of parkinsonism, whereas physiotherapy remains the best therapeutic option for CA. Only midodrine and droxidopa were found to be efficient for neurogenic hypotension in double-blind, controlled studies, whereas other symptoms of autonomic failure may be managed with off-label treatments. To date, no curative treatment is available for MSA. Recent results of neuroprotective and -restorative trials have provided some hope for future advances. Considerations for future clinical trials are also discussed in this review.

SUBMITTER: Perez-Lloret S 

PROVIDER: S-EPMC6183186 | biostudies-literature | 2015 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications


MSA is a progressive neurodegenerative disorder characterized by autonomic failure and a variable combination of poor levodopa-responsive parkinsonism and cerebellar ataxia (CA). Current therapeutic management is based on symptomatic treatment. Almost one third of MSA patients may benefit from l-dopa for the symptomatic treatment of parkinsonism, whereas physiotherapy remains the best therapeutic option for CA. Only midodrine and droxidopa were found to be efficient for neurogenic hypotension in  ...[more]

Similar Datasets

| S-EPMC7851250 | biostudies-literature
| S-EPMC8528757 | biostudies-literature
| S-EPMC3002658 | biostudies-literature
| S-EPMC7215736 | biostudies-literature
| S-EPMC3551813 | biostudies-literature
| S-EPMC10570409 | biostudies-literature
| S-EPMC6248513 | biostudies-literature
| S-EPMC8514113 | biostudies-literature
| S-EPMC7596458 | biostudies-literature
| S-EPMC4730554 | biostudies-literature